The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling-Reference-Cited by-同舟云学术

The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling

Published:2013-02-15 Issue:4 Volume:90 Page:263-272
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Kaiser Martin F.¹,Heider Ulrike¹,Mieth Maren¹,Zang Chuanbing¹,von Metzler Ivana¹,Sezer Orhan

Affiliation:

1. Department of Haematology and Oncology; Charité Universitätsmedizin Berlin; Berlin; Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12069/fullpdf

Reference42 articles.

1. Multiple myeloma;Kyle;N Engl J Med,2004

2. Myeloma and the newly diagnosed patient: a focus on treatment and management;Rajkumar;Semin Oncol,2002

3. Pathophysiology of multiple myeloma bone disease;Lentzsch;Hematol Oncol Clin North Am,2007

4. Myeloma bone disease: recent advances in biology, diagnosis, and treatment;Sezer;Oncologist,2009

5. The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group;Terpos;Leukemia,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-related disease: Bones;Aging;2024

2. Prevalence and clinical outcomes of vitamin D deficiency among Japanese multiple myeloma patients: a single-center observational study;Supportive Care in Cancer;2023-09

3. Preventing osteolytic lesions and osteomyelitis in multiple myeloma;Journal of Bone Oncology;2022-12

4. Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant Therapies;Nutrients;2022-04-26

5. Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies;International Journal of Molecular Sciences;2021-05-06